In patient 2, mutations in TP53, ERBB2 and APC, which were frequently mutated in colorectal tumors and involved in the WNT/β-catenin signalling pathway [31], might play important roles in tumorigenesis and could be possible drug targets [32, 33]. The gene discussed is ERBB2; the disease is colorectal neoplasm.